Charles Schwab Investment Management Inc Procept Bio Robotics Corp Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 453,429 shares of PRCT stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

453,429

Previous 417,043 8.72%

Holding current value

$15.6 Million

Previous $24.3 Million 7.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$48.82 - $65.05 $1.78 Million - $2.37 Million	36,386 Added 8.72%	453,429 $26.1 Million
Q1 2025 Sep 15, 2025	SELL	$56.03 - $88.57 $2.04 Million - $3.22 Million	-36,386 Reduced 8.02%	417,043 $24.3 Million
Q1 2025 May 09, 2025	SELL	$56.03 - $88.57 $526,177 - $831,760	-9,391 Reduced 2.2%	417,043 $24.3 Million
Q4 2024 Feb 06, 2025	BUY	$67.27 - $99.45 $1.61 Million - $2.37 Million	23,869 Added 5.93%	426,434 $34.3 Million
Q3 2024 Nov 12, 2024	BUY	$56.31 - $84.99 $2.63 Million - $3.97 Million	46,665 Added 13.11%	402,565 $32.2 Million
Q2 2024 Aug 12, 2024	BUY	$45.73 - $69.19 $668,069 - $1.01 Million	14,609 Added 4.28%	355,900 $21.7 Million
Q1 2024 May 08, 2024	BUY	$40.38 - $50.75 $249,306 - $313,330	6,174 Added 1.84%	341,291 $16.9 Million
Q4 2023 Feb 06, 2024	BUY	$24.89 - $43.41 $345,174 - $602,009	13,868 Added 4.32%	335,117 $14 Million
Q3 2023 Nov 08, 2023	BUY	$30.02 - $38.81 $2.09 Million - $2.7 Million	69,525 Added 27.62%	321,249 $10.5 Million
Q2 2023 Aug 09, 2023	BUY	$26.7 - $37.02 $682,345 - $946,083	25,556 Added 11.3%	251,724 $8.9 Million
Q1 2023 May 11, 2023	SELL	$26.64 - $39.74 $24,348 - $36,322	-914 Reduced 0.4%	226,168 $6.42 Million
Q4 2022 Feb 13, 2023	BUY	$38.78 - $46.78 $228,491 - $275,627	5,892 Added 2.66%	227,082 $9.43 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $4.02 Million - $6.59 Million	130,141 Added 142.94%	221,190 $9.17 Million
Q2 2022 Aug 15, 2022	BUY	$29.23 - $44.45 $1.16 Million - $1.76 Million	39,658 Added 77.17%	91,049 $2.98 Million
Q1 2022 May 13, 2022	BUY	$16.89 - $35.74 $20,369 - $43,102	1,206 Added 2.4%	51,391 $1.8 Million
Q4 2021 Feb 11, 2022	BUY	$24.6 - $46.29 $1.23 Million - $2.32 Million	50,185 New	50,185 $1.26 Million

Others Institutions Holding PRCT

# of Institutions

289

Shares Held

45.3M

Call Options Held

236K

Put Options Held

91.9K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.53B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Procept Bio Robotics Corp Transaction History